IMWG Series

The International Myeloma Working Group (IMWG) Conference Series: Making Sense of Treatment is a medical education program created by the International Myeloma Foundation (IMF) to bring lively expert discussion of important myeloma treatment issues into the homes and offices of viewers around the world via live webcast.

Dec
11
IMWG Conference Series: 59th Annual ASH Meeting Atlanta, GA
Watch Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson on December 11 at 5pm PT/7pm CT/8pm ET as they discuss the latest news and trends in the treatment of Multiple Myeloma at the 59th Annual ASH Meeting in Atlanta, Georgia. click here to download slides We thank our supporters of this program: Abbvie, AMGEN, Bristol-Myers Squibb, Celgene Corporation, Janssen Oncology, Takeda Oncology
Dec
18
ASH17: Role of Autologous Stem Cell Transplant (ASCT)
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses the Role of Autologous Stem Cell Transplant (ASCT) for mutiple myeloma during the IMWG Conference Series filmed at ASH 2017 in(...)
Dec
18
ASH 17: Maintenance Recommendations
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses the Maintenance Recommendations for Multiple Myeloma during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia.
Dec
18
ASH17: Early Relapse Management
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses Early Relapse Management during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia.
Dec
18
ASH 17: New Therapies
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses the New Therapies for Multiple Myeloma during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia.
Dec
18
ASH 17: Priorities for Early Disease
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses the Priorities for Early Disease including diagnosis and management of High-Risk Smoldering Myeloma during the IMWG Conference(...)
Dec
18
ASH17: Frontline Options
Drs. Brian G.M. Durie, Joseph Mikhael, and Paul Richardson discusses Frontline Options for multiple myeloma during the IMWG Conference Series filmed at ASH 2017 in Atlanta, Georgia. click here to(...)

Give Where Needed Most

$500
$250
$100
$50
other

Learn More

 

We would like to thank:

Amgen, Astellas Pharma, Binding Site, Bristol-Myers Squibb, Celgene, Diplomat Pharmacy, Genentech, Hoffman-La Roche, Janssen, Karyopharm Therapeutics, Merck, Novartis, Oncopeptides, Sanofi-Genzyme, Takeda Oncology